{"id":"W2587131117","doi":"10.1093/ecco-jcc/jjx002.034","title":"OP035 Efficacy and safety of abrilumab (AMG 181/MEDI 7183) therapy for moderate to severe Crohn's disease","year":2017,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Placebo; Gastroenterology; Clinical endpoint; Adverse effect; Crohn's disease; Double blind; Calprotectin; Randomized controlled trial; Inflammatory bowel disease; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001288417,0.000477544,0.001306651,0.0002297068,0.0001630953,0.0005632709,0.0004292412,0.0007087695,0.004170231],"category_scores_gemma":[0.001206462,0.0002081751,0.0006853564,0.0001917393,0.0004081229,0.0003727965,0.0002860877,0.001105463,0.0006926199],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002541702,"about_ca_system_score_gemma":0.0005184262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002875715,"about_ca_topic_score_gemma":0.0005049071,"domain_scores_codex":[0.999579,0.0002044055,0.00004419247,0.00004621245,0.00006015766,0.00006597607],"domain_scores_gemma":[0.9994003,0.0002126106,0.0001659766,0.00002731728,0.00003249187,0.0001613226],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.77179,0.01223049,0.003574086,0.002167024,0.0008881378,0.0002409518,0.00012701,0.0009477433,0.03363938,0.0002006614,0.001332871,0.1728618],"study_design_scores_gemma":[0.3871126,0.5654511,0.03767191,0.000197054,0.0009021411,0.000645584,0.00005782456,0.0009620705,0.003850499,0.0002176847,0.002890452,0.00004114069],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922941,0.004914796,0.0003339653,0.0002109294,0.00007910887,0.0004177452,0.0002667954,0.00005185524,0.001430766],"genre_scores_gemma":[0.9965079,0.00116709,0.0004472958,0.0003650215,0.0001017856,0.0003082558,0.0003340757,0.000007014782,0.0007614786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004170231,"threshold_uncertainty_score":0.01395082,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01009713487822983,"score_gpt":0.2686020102083588,"score_spread":0.258504875330129,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}